{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T23:26:55Z","timestamp":1780702015690,"version":"3.54.1"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,3,23]],"date-time":"2006-03-23T00:00:00Z","timestamp":1143072000000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2006,3]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Orthotopic liver transplantation (OLT) is the only effective curative therapy for end\u2010stage primary biliary cirrhosis (PBC). Survival after OLT is excellent, although recent data have shown a recurrence rate of PBC of up to 32% after transplantation. The aim of this study is to investigate the course after disease recurrence, particularly with regard to liver function and survival in a long\u2010term follow\u2010up. Between April 1989 and April 2003, 1553 liver transplantations were performed in 1415 patients at the Charit\u00e9, Virchow Clinic. Protocol liver biopsies were taken after one, three, five, seven, 10 and 13\u2003yr. One hundred (7%) patients suffered from histologically proven PBC. Primary immunosuppression consisted of cyclosporine (n=54) or tacrolimus (Tac) (n=46). Immediately after OLT, all patients received ursodeoxycholic acid. Corticosteroids were withdrawn three to six months after OLT. The median age of the 85 women and 15 men was 55\u2003yr (range 25\u201366\u2003yr). The median follow\u2010up after liver transplantation was 118 months (range 16\u2013187 months) and after recurrence 30 months (range 4\u201379 months). Actuarial patient survival after five, 10 and 15\u2003yr was 87, 84 and 82% respectively. Ten patients (10%) died after a median survival time of 32 months. Two of these patients developed organ dysfunction owing to recurrence of PBC. Histological recurrence was found in 14 patients (14%) after a median time of 61 months (range 36\u2013122 months). Patients with Tac immunosuppression developed PBC recurrence more often (p&lt;0.05) and also earlier (p&lt;0.05). Fifty\u2010seven patients developed an acute rejection and two patients a chronic rejection episode. Liver function did not alter within the first five\u2003yr after histologically proven PBC recurrence. Multivariate analysis of the investigated patients showed that the recipient's age and Tac immunosuppression were significant risk factors for PBC recurrence. Long\u2010term follow\u2010up of up to 15\u2003yr after liver transplantation, owing to PBC, in addition to maintenance of liver function, shows excellent organ and patient survival rates. Although protocol liver biopsies revealed histological recurrence in 14 (14%) patients, only two patients developed graft dysfunction. Tac\u2010treated patients showed more frequently and also earlier histologically proven PBC recurrence; however, in our population we could not observe an impact on graft dysfunction and patient's survival.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2005.00471.x","type":"journal-article","created":{"date-parts":[[2006,3,23]],"date-time":"2006-03-23T09:47:46Z","timestamp":1143107266000},"page":"211-220","source":"Crossref","is-referenced-by-count":110,"title":["Long\u2010term follow\u2010up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients"],"prefix":"10.1111","volume":"20","author":[{"given":"Dietmar A.","family":"Jacob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf P.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Bahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Klupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gero","family":"Puhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Langrehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,3,23]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-195012000-00002"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05419-6"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.50132"},{"key":"e_1_2_5_5_2","first-page":"1053","article-title":"Randomised controlled trials of ursodeoxycholic\u2010acid therapy for primary biliary cirrhosis","volume":"354","author":"Goulis J","year":"1999","journal-title":"a meta-analysis"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290140"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200201270-00012"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198201073060101"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1996.tb01586.x"},{"key":"e_1_2_5_10_2","first-page":"1086","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation","volume":"9","author":"Sylvestre PB","year":"2003","journal-title":"histologic estimate of incidence and natural history"},{"key":"e_1_2_5_11_2","first-page":"87","article-title":"Liver transplantation for primary biliary cirrhosis","volume":"9","author":"Khettry U","year":"2003","journal-title":"a long-term pathologic study"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(03)00064-2"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.50096"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199611213352107"},{"key":"e_1_2_5_15_2","first-page":"22","article-title":"Transplantation for primary biliary cirrhosis","volume":"33","author":"Liermann Garcia RF","year":"2001","journal-title":"retrospective analysis of 400 patients in a single center"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80206-5"},{"key":"e_1_2_5_17_2","first-page":"205","article-title":"Complications of percutaneous liver biopsy in patients after liver transplantation","volume":"37","author":"Lang M","year":"1999","journal-title":"Z Gastroenterol"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199306000-00021"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00195875"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199404000-00014"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91592-4"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.500030620"},{"key":"e_1_2_5_23_2","first-page":"658","article-title":"Banff schema for grading liver allograft rejection","volume":"25","year":"1997","journal-title":"an international consensus document"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197309272891306"},{"key":"e_1_2_5_25_2","first-page":"38","article-title":"Liver transplantation in primary biliary cirrhosis","volume":"62","author":"Rust C","year":"2000","journal-title":"risk assessment and 11-year follow-up"},{"key":"e_1_2_5_26_2","first-page":"538","article-title":"Long\u2010term outcome of liver transplantation in patients with PSC","volume":"99","author":"Maheshwari A","year":"2004","journal-title":"a comparative analysis with PBC"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80244-2"},{"key":"e_1_2_5_28_2","first-page":"176A","article-title":"Transplantation for primary cirrhosis","volume":"26","author":"Abu\u2010Elamgd KDJ","year":"1997","journal-title":"recurrence and outcome in 421 patients"},{"key":"e_1_2_5_29_2","first-page":"253","article-title":"Recurrence of primary biliary cirrhosis in the liver allograft","volume":"24","author":"Dmitrewski J","year":"1996","journal-title":"the effect of immunosuppression"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000090867.83666.F7"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20123"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2005.00471.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2005.00471.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T04:26:35Z","timestamp":1696911995000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2005.00471.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["10.1111\/j.1399-0012.2005.00471.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2005.00471.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}